[1]
Lichtenfels, M. et al. 2026. VALIDATION OF A NOVEL IN VITRO BREAST CANCER CHEMORESISTANCE PLATFORM IN NEOADJUVANT SETTING. Mastology. 32, suppl.2 (Apr. 2026). DOI:https://doi.org/10.29289/259453942022V32S2013.